Skip to main content
. 2018 Jan 4;2(1):e1. doi: 10.2196/cardio.8199

Table 2.

Agreement in step counts between X6 accelerometer and wrist-worn devices.


Group
FBTa GARb

n

ρ (P value)
Differencec
(IQR)d

Error
(IQR)
P; PU/Le
n

ρ (P value)

Difference
(IQR)

Error
(IQR)

P; PU/L
All participants 36 .78 (<.001) 463
(−220 to 924)
32.9%
(8.3-52.5)
.002; .99 33 .65 (<.001) 963
(59-1390)
40.9%
(14.9-69.5)
.008; break/>.99
No gait aid 13 .97 (<.001) −203
(−288 to 339)
10.3%
(5.5-30.4)
.85; .32 11 .56 (.07) −561
(−1960 to 971)
23.1%
(14.7-46.1)
.28; break/>0.77
Rollator 15 .42 (.12) 926
(386-1939)
52.3%
(39.9-56.9)
.01; .99 15 .30 (.27) 1390
(283-2376)
67.2%
(26.2-73.0)
.001; break/>>.99
Single-point cane 8 .98 (<.001) 406
(−18 to 912)
12.6%
(5.8-22.3)
.08; .90 7 .93 (.003) 963
(377-1330)
21.3%
(15.0-41.1)
.02; break/>.99

aFBT: Fitbit Charge HR.

bGAR: Garmin Vivosmart.

cThe difference is calculated as the X6 accelerometer step count minus the wrist device step count; therefore, a positive value means the wrist-worn device undercounted, whereas a negative value means the wrist-worn device overcounted.

dIQR: interquartile range

dP values are for Wilcoxon signed rank tests: two-sided to compare median step counts of the devices and one-sided testing of whether the median difference is significantly different from a lower (PL) and upper (PU) limit (the greater of the 2 is reported).